Literature DB >> 18638552

Understanding mechanisms governing protein-protein interactions from synthetic binding interfaces.

Anthony A Kossiakoff1, Shohei Koide.   

Abstract

Recent advances in methodologies and design of combinatorial library selection have enabled comprehensive characterization of sequence space for protein-protein interaction interfaces and generation of fully synthetic binding interfaces. By exhaustively introducing and quantitatively analyzing mutations in natural interfaces, new insights into their molecular architecture and plasticity have emerged. Minimalist combinatorial libraries based on a restricted amino acid code have produced synthetic interfaces that rival natural ones using a different set of rules. A two amino acid code composed of just tyrosine and serine in the context of antibody CDR loops is sufficient to produce high affinity and specific interactions with different classes of protein targets. Structural analyses highlight the dominant role of Tyr in forming productive interactions and demonstrate the dominance of conformational diversity over chemical diversity in producing naïve binding interfaces. Synthetic binding proteins are beginning to be used as a powerful crystallization tool to attack important structural biology problems that are recalcitrant to crystallization using traditional methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638552     DOI: 10.1016/j.sbi.2008.06.004

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  13 in total

Review 1.  Structural anatomy of telomere OB proteins.

Authors:  Martin P Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10       Impact factor: 8.250

2.  Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.

Authors:  David J Culpepper; Michael K Maddox; Andrew B Caldwell; Benjamin J McFarland
Journal:  Mol Immunol       Date:  2010-11-12       Impact factor: 4.407

3.  Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Authors:  Ara Celi DiCostanzo; James R Thompson; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

4.  Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.

Authors:  Preeti Sharma; David M Kranz
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

5.  A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor.

Authors:  Scott T R Walsh
Journal:  Biochemistry       Date:  2010-09-15       Impact factor: 3.162

Review 6.  Unmet challenges of structural genomics.

Authors:  Maksymilian Chruszcz; Marcin Domagalski; Tomasz Osinski; Alexander Wlodawer; Wladek Minor
Journal:  Curr Opin Struct Biol       Date:  2010-08-31       Impact factor: 6.809

7.  Assessing helical protein interfaces for inhibitor design.

Authors:  Brooke N Bullock; Andrea L Jochim; Paramjit S Arora
Journal:  J Am Chem Soc       Date:  2011-08-22       Impact factor: 15.419

8.  Contribution of light chain residues to high affinity binding in an HIV-1 antibody explored by combinatorial scanning mutagenesis.

Authors:  Gustavo F Da Silva; Joseph S Harrison; Jonathan R Lai
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

9.  Thermodynamic additivity of sequence variations: an algorithm for creating high affinity peptides without large libraries or structural information.

Authors:  Matthew P Greving; Paul E Belcher; Chris W Diehnelt; Maria J Gonzalez-Moa; Jack Emery; Jinglin Fu; Stephen Albert Johnston; Neal W Woodbury
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

10.  Side chain requirements for affinity and specificity in D5, an HIV-1 antibody derived from the VH1-69 germline segment.

Authors:  Alex Stewart; Joseph S Harrison; Lauren K Regula; Jonathan R Lai
Journal:  BMC Biochem       Date:  2013-04-08       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.